Deflazacort Oral Suspension
NDC 70377-188, Deflazacort Oral, suspension, from Biocon Pharma Inc..
- Product NDC
- 70377-188
- Status
- Listed
- Labeler
- Biocon Pharma Inc.
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA220709
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70377-188 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DEFLAZACORT22.75 mg/mL
Pharmacologic classes
Corticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70377-188-21 | 70377018821 | 1 BOTTLE in 1 CARTON (70377-188-21) / 13 mL in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/e76f35a5-711c-c511-9fd8-b8c4c0b43b85
Use it
Look up 70377-188 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70377-188 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70377-188. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.